NM_000860.6(HPGD):c.650A>G (p.Tyr217Cys) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Aug 14, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002032259.5

Allele description [Variation Report for NM_000860.6(HPGD):c.650A>G (p.Tyr217Cys)]

NM_000860.6(HPGD):c.650A>G (p.Tyr217Cys)

Gene:

HPGD:15-hydroxyprostaglandin dehydrogenase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

4q34.1

Genomic location:

Preferred name:

NM_000860.6(HPGD):c.650A>G (p.Tyr217Cys)

HGVS:

NC_000004.12:g.174493163T>C
NG_011689.1:g.34479A>G
NM_000860.6:c.650A>GMANE SELECT
NM_001145816.3:c.499-1069A>G
NM_001256301.1:c.287A>G
NM_001256305.2:c.422-1069A>G
NM_001256306.2:c.446A>G
NM_001256307.2:c.287A>G
NP_000851.2:p.Tyr217Cys
NP_001243230.1:p.Tyr96Cys
NP_001243235.1:p.Tyr149Cys
NP_001243236.1:p.Tyr96Cys
NC_000004.11:g.175414314T>C

Protein change:

Y149C

Links:

dbSNP: rs140209262

NCBI 1000 Genomes Browser:

rs140209262

Molecular consequence:

NM_001145816.3:c.499-1069A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001256305.2:c.422-1069A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_000860.6:c.650A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001256301.1:c.287A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001256306.2:c.446A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001256307.2:c.287A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002315116	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Aug 14, 2021)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002315116

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Aug 14, 2021)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002315116.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change replaces tyrosine with cysteine at codon 217 of the HPGD protein (p.Tyr217Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. This variant is present in population databases (rs140209262, ExAC 0.005%). This variant has not been reported in the literature in individuals affected with HPGD-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine